A print friendly PDF version is available from this Communicable Diseases Intelligence issue's table of contents.
There were 4,658 notifications to the National Notifiable Diseases Surveillance System (NNDSS) in the four week period, 14 October to 10 November 1998 (Tables 1 and 2). The numbers of reports for selected diseases have been compared with historical data for corresponding periods in the previous three years (Figure 3).
There were 2,536 reports received by the Virology and Serology Laboratory Reporting Scheme (LabVISE) in the four week period, 8 October to 4 November 1998 (Tables 3 and 4).
The Australian Sentinel Practice Research Network (ASPREN) data for weeks 40 to 43, ending 1 November 1998, are included in this issue of CDI (Table 5).
Figure 3. Selected National Notifiable Diseases Surveillance System reports, and historical data.1
1. The historical data are the averages of the number of notifications in the corresponding 4 week periods of the last 3 years and the 2 week periods immediately preceding and following those
Top of pageTable 1. Notifications of diseases preventable by vaccines recommended by the NHMRC for routine childhood immunisation, received by State and Territory health authorities in the period 14 October to 10 November 1998
Disease1,2 |
ACT | NSW | NT | Qld | SA | Tas | Vic | WA | This period 1998 | This period 1997 | Year to date 1998 | Year to date 1997 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Diphtheria | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
H. influenzae type b infection | 0 |
0 |
0 |
2 |
0 |
0 |
0 |
0 |
2 |
1 |
28 |
44 |
Measles3 | 3 |
6 |
0 |
0 |
1 |
1 |
2 |
0 |
13 |
143 |
298 |
662 |
Mumps | 0 |
1 |
1 |
0 |
0 |
1 |
2 |
1 |
6 |
9 |
154 |
169 |
Pertussis | 16 |
100 |
1 |
105 |
22 |
7 |
65 |
8 |
324 |
1,096 |
5,678 |
7,671 |
Rubella4 | 2 |
4 |
0 |
26 |
0 |
1 |
10 |
5 |
48 |
116 |
721 |
1,275 |
1. No notification of poliomyelitis has been received since 1986.
2. Totals comprise data from all States and Territories. Cumulative figures are subject to retrospective revision, so there may be discrepancies between the number of new notifications and the increment in the cumulative figure from the previous period.
3. The total number of measles notifications for 1998 has been revised downwards because of a reclassification of 79 cases previously notified as measles by Victoria. These cases have been reclassified as not measles following results of serology.
4. Includes congenital rubella.
Table 2. Notifications of diseases received by State and Territory health authorities in the period 14 October to 10 November 1998.
Disease1,2,3,4 |
ACT | NSW | NT | Qld | SA | Tas | Vic | WA | This period 1998 | This period 1997 | Year to date 19985 | Year to date 1997 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Arbovirus infection (NEC)6 | 0 |
1 |
0 |
1 |
0 |
0 |
0 |
0 |
2 |
4 |
66 |
82 |
Barmah Forest virus infection | 0 |
1 |
0 |
14 |
0 |
0 |
0 |
1 |
16 |
29 |
494 |
642 |
Brucellosis | 0 |
0 |
0 |
4 |
0 |
0 |
1 |
0 |
5 |
1 |
41 |
31 |
Campylobacteriosis7 | 22 |
- |
18 |
420 |
279 |
33 |
385 |
172 |
1,329 |
935 |
10,303 |
9,799 |
Chlamydial infection (NEC)8 | 10 |
NN |
77 |
388 |
89 |
12 |
167 |
117 |
860 |
634 |
9,418 |
7,760 |
Cholera | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
4 |
3 |
Dengue | 2 |
2 |
0 |
30 |
0 |
0 |
0 |
1 |
35 |
5 |
429 |
204 |
Donovanosis | 0 |
NN |
0 |
0 |
NN |
0 |
0 |
0 |
0 |
0 |
30 |
28 |
Gonococcal infection9 | 3 |
56 |
137 |
112 |
23 |
1 |
53 |
63 |
448 |
227 |
4,680 |
3,992 |
Hepatitis A | 1 |
18 |
3 |
96 |
10 |
0 |
7 |
9 |
144 |
221 |
2,375 |
2,737 |
Hepatitis B incident5 | 0 |
2 |
1 |
3 |
5 |
0 |
4 |
0 |
15 |
14 |
208 |
216 |
Hepatitis C incident10 | 2 |
8 |
0 |
- |
3 |
2 |
- |
- |
23 |
2 |
282 |
60 |
Hepatitis C unspecified5 | 16 |
NN |
26 |
218 |
NN |
25 |
16 |
89 |
390 |
687 |
7,872 |
8,301 |
Hepatitis (NEC) | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
NN |
0 |
0 |
4 |
5 |
Haemolytic uraemic syndrome11 | NN |
0 |
NN |
0 |
1 |
0 |
NN |
0 |
1 |
NA |
11 |
NA |
Hydatid infection | 0 |
0 |
0 |
0 |
0 |
0 |
2 |
0 |
2 |
4 |
38 |
48 |
Legionellosis | 0 |
1 |
0 |
4 |
4 |
0 |
19 |
3 |
31 |
11 |
215 |
125 |
Leprosy | 0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
2 |
10 |
Leptospirosis | 0 |
0 |
0 |
10 |
0 |
0 |
4 |
0 |
14 |
10 |
148 |
106 |
Listeriosis | 0 |
1 |
0 |
2 |
1 |
0 |
2 |
0 |
6 |
3 |
47 |
65 |
Malaria | 1 |
5 |
0 |
9 |
2 |
0 |
5 |
5 |
27 |
15 |
622 |
691 |
Meningococcal infection | 1 |
13 |
4 |
7 |
1 |
1 |
5 |
2 |
34 |
48 |
409 |
435 |
Ornithosis | 0 |
NN |
0 |
0 |
0 |
0 |
6 |
0 |
6 |
0 |
34 |
41 |
Q fever | 0 |
9 |
0 |
20 |
1 |
0 |
0 |
1 |
31 |
44 |
490 |
518 |
Ross River virus infection | 2 |
8 |
1 |
27 |
4 |
0 |
2 |
6 |
50 |
58 |
2,535 |
6,455 |
Salmonellosis (NEC) | 8 |
72 |
33 |
163 |
35 |
9 |
131 |
61 |
512 |
414 |
6,782 |
5,985 |
Shigellosis7 | 0 |
- |
9 |
19 |
5 |
0 |
9 |
6 |
48 |
54 |
537 |
696 |
SLTEC, VTEC12 | NN |
0 |
NN |
NN |
0 |
0 |
NN |
NN |
1 |
NA |
15 |
NA |
Syphilis13 | 1 |
19 |
38 |
39 |
2 |
1 |
0 |
2 |
102 |
89 |
1,306 |
1,111 |
Tuberculosis | 0 |
11 |
5 |
8 |
1 |
0 |
28 |
5 |
58 |
76 |
835 |
818 |
Typhoid14 | 0 |
2 |
0 |
0 |
2 |
0 |
0 |
0 |
4 |
8 |
66 |
67 |
Yersiniosis (NEC)7 | 0 |
- |
0 |
6 |
4 |
0 |
0 |
0 |
10 |
13 |
187 |
212 |
1. Diseases preventable by routine childhood immunisation are presented in Table 1.
2. For HIV and AIDS, see Tables 3 and 4.
3. Totals comprise data from all States and Territories. Cumulative figures are subject to retrospective revision so there may be discrepancies between the number of new notifications and the increment in the cumulative figure from the previous period.
4. No notifications have been received during 1998 for the following rare diseases: botulism (foodborne), lymphogranuloma venereum, plague, rabies, yellow fever, or other viral haemorrhagic fevers. There have also been no cases of thrombotic thrombocytopaenic purpura (TTP), which became nationally reportable in August 1998.
5. Data from Victoria for 1998 are incomplete.
6. NT: includes Barmah Forest virus.
7. Not reported for NSW because it is only notifiable as 'foodborne disease' or 'gastroenteritis in an institution'.
8. WA: genital only.
9. NT, Qld, SA and Vic: includes gonococcal neonatal ophthalmia.
10. Qld and Vic incident cases of Hepatitis C are not separately reported.
11. Nationally reportable from August 1998.
12. Infections with Shiga-like toxin (verotoxin) producing E. Coli (SLTEC/VTEC) became nationally reportable in August 1998.
13. Includes congenital syphilis.
14. NSW, Qld, Vic: includes paratyphoid.
NN Not Notifiable.
NEC Not Elsewhere Classified.
- Elsewhere Classified.
NA Not applicable, as reporting for this condition did not commence until 1998.
Table 3. Virology and serology laboratory reports by State or Territory1 for the reporting period 8 October to 4 November 1998, and total reports for the year.
State or Territory1 | Total this period | Total reported in CDI in 1998 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
ACT | NSW | NT | Qld | SA | Tas | Vic | WA | |||
Measles, mumps, rubella |
||||||||||
Measles virus | 1 |
1 |
2 |
54 |
||||||
Mumps virus | 2 |
1 |
3 |
6 |
43 |
|||||
Rubella virus | 4 |
1 |
2 |
7 |
103 |
|||||
Hepatitis viruses | ||||||||||
Hepatitis A virus | 1 |
4 |
4 |
1 |
6 |
16 |
343 |
|||
Hepatitis D virus | 1 |
1 |
6 |
|||||||
Arboviruses |
||||||||||
Ross River virus | 8 |
1 |
1 |
5 |
15 |
612 |
||||
Barmah Forest virus | 1 |
1 |
2 |
30 |
||||||
Dengue not typed | 2 |
2 |
4 |
36 |
||||||
Flavivirus (unspecified) | 1 |
3 |
4 |
64 |
||||||
Adenoviruses |
||||||||||
Adenovirus type 1 | 23 |
1 |
24 |
63 |
||||||
Adenovirus type 2 | 1 |
2 |
3 |
23 |
||||||
Adenovirus type 3 | 7 |
2 |
9 |
47 |
||||||
Adenovirus type 4 | 2 |
2 |
4 |
|||||||
Adenovirus type 6 | 5 |
5 |
15 |
|||||||
Adenovirus type 7 | 1 |
1 |
17 |
|||||||
Adenovirus type 8 | 1 |
1 |
6 |
|||||||
Adenovirus type 22 | 1 |
1 |
2 |
|||||||
Adenovirus type 40 | 2 |
2 |
13 |
|||||||
Adenovirus not typed/pending | 25 |
3 |
49 |
1 |
15 |
12 |
105 |
752 |
||
Herpes viruses |
||||||||||
Cytomegalovirus | 10 |
7 |
14 |
2 |
41 |
7 |
81 |
707 |
||
Varicella-zoster virus | 5 |
13 |
16 |
1 |
64 |
21 |
120 |
1,118 |
||
Epstein-Barr virus | 10 |
1 |
40 |
85 |
26 |
16 |
178 |
1,596 |
||
Other DNA viruses |
||||||||||
Papovavirus group | 1 |
1 |
3 |
|||||||
Parvovirus | 3 |
4 |
19 |
6 |
32 |
220 |
||||
Picornavirus family |
||||||||||
Coxsackievirus A9 | 1 |
1 |
6 |
|||||||
Coxsackievirus B4 | 1 |
1 |
2 |
8 |
||||||
Coxsackievirus B5 | 1 |
1 |
4 |
|||||||
Echovirus type 18 | 1 |
1 |
7 |
|||||||
Poliovirus type 1 (uncharacterised) | 1 |
1 |
7 |
|||||||
Poliovirus type 3 (uncharacterised) | 1 |
1 |
4 |
|||||||
Rhinovirus (all types) | 17 |
9 |
8 |
34 |
407 |
|||||
Enterovirus not typed/pending | 3 |
4 |
1 |
1 |
3 |
19 |
31 |
428 |
||
Ortho/paramyxoviruses |
||||||||||
Influenza A virus | 53 |
1 |
3 |
122 |
1 |
33 |
33 |
246 |
2,744 |
|
Influenza B virus | 11 |
2 |
13 |
165 |
||||||
Parainfluenza virus type 1 | 5 |
1 |
6 |
276 |
||||||
Parainfluenza virus type 2 | 1 |
1 |
32 |
|||||||
Parainfluenza virus type 3 | 4 |
16 |
6 |
14 |
40 |
320 |
||||
Respiratory syncytial virus | 116 |
6 |
278 |
80 |
312 |
46 |
838 |
4,688 |
||
Other RNA viruses |
||||||||||
HTLV-1 | 1 |
1 |
2 |
18 |
||||||
Rotavirus | 72 |
3 |
52 |
17 |
122 |
13 |
279 |
1,175 |
||
Norwalk agent | 7 |
7 |
37 |
|||||||
Other |
||||||||||
Chlamydia trachomatis not typed | 19 |
8 |
28 |
58 |
11 |
20 |
55 |
199 |
3,082 |
|
Chlamydia psittaci | 12 |
1 |
13 |
53 |
||||||
Mycoplasma pneumoniae | 13 |
16 |
34 |
58 |
6 |
127 |
1,216 |
|||
Coxiella burnetii (Q fever) | 4 |
2 |
1 |
3 |
2 |
12 |
109 |
|||
Bordetella pertussis | 15 |
41 |
2 |
58 |
890 |
|||||
Legionella longbeachae | 1 |
1 |
29 |
|||||||
Total | 351 |
19 |
158 |
796 |
114 |
819 |
279 |
2,536 |
21,582 |
1. State or Territory of postcode, if reported, otherwise State or Territory of reporting laboratory.
Top of pageTable 4. Virology and serology laboratory reports by contributing laboratories for the reporting period 8 October to 4 November 1998.
State or Territory |
Laboratory |
Reports |
---|---|---|
New South Wales | New Children's Hospital, Westmead Royal Prince Alfred Hospital, Camperdown South West Area Pathology Service, Liverpool |
178 53 113 |
Queensland | Queensland Medical Laboratory, West End Townsville General Hospital |
162 8 |
South Australia | Institute of Medical and Veterinary Science, Adelaide | 796 |
Tasmania | Northern Tasmanian Pathology Service, Launceston Royal Hobart Hospital, Hobart |
28 84 |
Victoria |
Monash Medical Centre, Melbourne Royal Children's Hospital, Melbourne Victorian Infectious Diseases Reference Laboratory, Fairfield |
47 546 231 |
Western Australia |
PathCentre Virology, Perth Princess Margaret Hospital, Perth Western Diagnostic Pathology |
250 25 15 |
Total | 2,536 |
Table 5. Australian Sentinel Practice Research Network reports, weeks 40 to 43, 1998.
Week number |
40 | 41 | 42 | 43 | ||||
---|---|---|---|---|---|---|---|---|
Week ending on | 11 October 1998 |
18 October 1998 |
25 October 1998 |
1 November 1998 |
||||
Doctors reporting | 51 |
57 |
54 |
54 |
||||
Total encounters | 6157 |
7663 |
6589 |
7037 |
||||
Condition |
Reports | Rate per 1,000 encounters | Reports | Rate per 1,000 encounters | Reports | Rate per 1,000 encounters | Reports | Rate per 1,000 encounters |
Influenza | 25 |
4.1 |
31 |
4.0 |
22 |
3.3 |
20 |
2.8 |
Rubella | 5 |
0.8 |
3 |
0.4 |
0 |
0.0 |
1 |
0.1 |
Measles | 0 |
0.0 |
0 |
0.0 |
0 |
0.0 |
0 |
0.0 |
Chickenpox | 6 |
1.0 |
14 |
1.8 |
10 |
1.5 |
14 |
2.0 |
Pertussis | 4 |
0.6 |
1 |
0.1 |
2 |
0.3 |
8 |
1.1 |
HIV testing (patient initiated) | 11 |
1.8 |
4 |
0.5 |
14 |
2.1 |
11 |
1.6 |
HIV testing (doctor initiated) | 4 |
0.6 |
10 |
1.3 |
7 |
1.1 |
3 |
0.4 |
Td (ADT) vaccine | 41 |
6.7 |
46 |
6.0 |
37 |
5.6 |
49 |
7.0 |
Pertussis vaccination | 37 |
6.0 |
49 |
6.4 |
40 |
6.1 |
43 |
6.1 |
Reaction to pertussis vaccine | 2 |
0.3 |
4 |
0.5 |
0 |
0.0 |
1 |
0.1 |
Ross River virus infection | 3 |
0.5 |
3 |
0.4 |
0 |
0.0 |
0 |
0.0 |
Gastroenteritis | 94 |
15.3 |
79 |
10.3 |
62 |
9.4 |
63 |
9.0 |
The NNDSS is conducted under the auspices of the Communicable Diseases Network Australia New Zealand. The system coordinates the national surveillance of more than 40 communicable diseases or disease groups endorsed by the National Health and Medical Research Council (NHMRC). Notifications of these diseases are made to State and Territory health authorities under the provisions of their respective public health legislations. De-identified core unit data are supplied fortnightly for collation, analysis and dissemination. For further information, see Commun Dis Intell 1998;22:4-5.
The NNDSS is conducted under the auspices of the Communicable Diseases Network Australia New Zealand. The system coordinates the national surveillance of more than 40 communicable diseases or disease groups endorsed by the National Health and Medical Research Council (NHMRC). Notifications of these diseases are made to State and Territory health authorities under the provisions of their respective public health legislations. De-identified core unit data are supplied fortnightly for collation, analysis and dissemination. For further information, see Commun Dis Intell 1998;22:4-5.
The NNDSS is conducted under the auspices of the Communicable Diseases Network Australia New Zealand. The system coordinates the national surveillance of more than 40 communicable diseases or disease groups endorsed by the National Health and Medical Research Council (NHMRC). Notifications of these diseases are made to State and Territory health authorities under the provisions of their respective public health legislations. De-identified core unit data are supplied fortnightly for collation, analysis and dissemination. For further information, see Commun Dis Intell 1998;22:4-5.
The NNDSS is conducted under the auspices of the Communicable Diseases Network Australia New Zealand. The system coordinates the national surveillance of more than 40 communicable diseases or disease groups endorsed by the National Health and Medical Research Council (NHMRC). Notifications of these diseases are made to State and Territory health authorities under the provisions of their respective public health legislations. De-identified core unit data are supplied fortnightly for collation, analysis and dissemination. For further information, see Commun Dis Intell 1998;22:4-5.
LabVISE is a sentinel reporting scheme. Twenty-one laboratories contribute data on the laboratory identification of viruses and other organisms. Data are collated and published in Communicable Diseases Intelligence every four weeks. These data should be interpreted with caution as the number and type of reports received is subject to a number of biases. For further information, see Commun Dis Intell 1998;22:8.
ASPREN currently comprises about 100 general practitioners from throughout the country. Up to 9,000 consultations are reported each week, with special attention to 12 conditions chosen for sentinel surveillance in 1998. CDI reports the consultation rates for all of these. For further information, including case definitions, see Commun Dis Intell 1998;22:5-6.
This article was published in Communicable Diseases Intelligence Volume 22, No 12, 26 November 1998.
CDI Search
Communicable Diseases Intelligence subscriptions
Sign-up to email updates: Subscribe Now
Communicable Diseases Surveillance
This issue - Vol 22, No 12, 26 November 1998
Communicable Diseases Intelligence